Cargando…

Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review

Immunohistochemical stains are increasingly used to aid in the diagnosis of malignant melanoma, especially when the differentiation of the tumor is unclear based on examination with hematoxylin and eosin. However, aberrant expression of non-melanocytic markers has been reported in melanomas, which c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saliba, Elie, Bhawan, Jag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395931/ https://www.ncbi.nlm.nih.gov/pubmed/34449584 http://dx.doi.org/10.3390/dermatopathology8030040

Ejemplares similares

Histopathological Variants of Cutaneous Neurofibroma: A Compendious Review
por: Nagrani, Neha S., et al.
Publicado: (2022)

Adnexotropic Variants of the Interface Dermatitides: A Review
por: Stephan, Carla, et al.
Publicado: (2021)

Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis
por: Tokuo, Hiroshi, et al.
Publicado: (2018)

Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review
por: Gajdzis, Malgorzata, et al.
Publicado: (2021)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

Cutaneous Myopericytoma: A Report of 3 Cases and Review of the Literature
por: Aung, Phyu P., et al.
Publicado: (2015)

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
por: Wu, Yan, et al.
Publicado: (2021)

Aberrant expression of p53 gene product in malignant melanoma.
por: Rhim, K. J., et al.
Publicado: (1994)

HOX Gene Aberrant Expression in Skin Melanoma: A Review
por: Piérard, Gérald E., et al.
Publicado: (2012)

Amelanotic Anorectal Malignant Melanoma: Case Report with Immunohistochemical Study and Literature Review
por: Laforga Canales, Juan B., et al.
Publicado: (2009)

Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
por: Rajabi, Parvin, et al.
Publicado: (2017)

Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives
por: Cazzato, Gerardo, et al.
Publicado: (2023)

“Melanocytic Nests Arising in Lichenoid Inflammation”: Reappraisal of the Terminology “Melanocytic Pseudonests”
por: Chung, Hye Jin, et al.
Publicado: (2015)

Plasmacytoid Melanoma of the Urinary Bladder and Lymph Nodes with Immunohistochemical Expression of Plasma Cell Markers Revealing Primary Esophageal Melanoma
por: Charfi, Slim, et al.
Publicado: (2012)

CD31 and CD34 Expression as Immunohistochemical Markers of Endothelial Transdifferentiation in Human Cutaneous Melanoma
por: Pisacane, A. M., et al.
Publicado: (2007)

Gastrin-Releasing Peptide-Expressing Nerves Comprise Subsets of Human Cutaneous Aδ and C Fibers that May Sense Pruritus
por: Timmes, Theresa R, et al.
Publicado: (2013)

Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature
por: Almeida, Luis Eduardo, et al.
Publicado: (2023)

Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma
por: Fujiwara, Susumu, et al.
Publicado: (2019)

Oral malignant melanoma of the lower jaw—a case report with immunohistochemical investigations
por: Tamgadge, Sandhya, et al.
Publicado: (2023)

Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma
por: Fernandes, Bruno F, et al.
Publicado: (2007)

RhoA and vigilin are candidates for immunohistochemical markers for epithelioid malignant mesothelioma
por: Hiratsuka, Takuya, et al.
Publicado: (2022)

Melanoma Inhibitory Activity and Melanoma Inhibitory Activity 2 as Novel Immunohistochemical Markers of Oral Epithelial Dysplasia
por: Kawai, Ryoko, et al.
Publicado: (2021)

Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions
por: Parente, Paola, et al.
Publicado: (2008)

Malignant Melanoma: A Pictorial Review
por: McCourt, Collette, et al.
Publicado: (2014)

Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
por: Maekawa, Naoya, et al.
Publicado: (2016)

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium
por: Al-Kaabi, Methaq, et al.
Publicado: (2022)

The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus
por: Cazzato, Gerardo, et al.
Publicado: (2022)

Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary – a review
por: Jung, Dennis, et al.
Publicado: (2023)

Immunohistochemical expression of Skp2 protein in oral nevi and melanoma
por: Benevenuto-de-Andrade, Bruno A., et al.
Publicado: (2013)

KIT Somatic Mutations and Immunohistochemical Expression in Canine Oral Melanoma
por: Brocca, Ginevra, et al.
Publicado: (2020)

Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2018)

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies
por: Utikal, Jochen, et al.
Publicado: (2007)

Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
por: Pastor, Nieves, et al.
Publicado: (2020)

Vulvar Malignant Melanoma: A Narrative Review
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

Malignant Melanoma
por: Perera, Eshini, et al.
Publicado: (2013)

Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
por: Shaker, Nada, et al.
Publicado: (2022)

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
por: Micevic, Goran, et al.
Publicado: (2017)

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Treatment of facial and non‐facial lentigines with a 730 nm picosecond titanium: Sapphire laser is safe and effective
por: Kauvar, Arielle N. B., et al.
Publicado: (2021)

Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study
por: Cazzato, Gerardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ejq554mn835u2d40v13ke5hlc